Lena Biosciences

Lena Biosciences is a biotechnology company founded in 2008, with headquarters in the United States. The company specializes in simplifying 3D cell culture and addressing common issues encountered by scientists in the lab. Lena Biosciences offers advanced Perfused-Organ-Panel (MPS) technology and 3D cell culture products and services catering to biomedical research and in vitro drug testing. Their patented technologies are transforming cancer research and personalized drug testing by optimizing conditions for cell growth and providing accurate in vitro models. The company's mission is to streamline organ-on-a-chip technologies for researchers of all skill levels, with the aim to expedite scientific discovery. One of Lena Biosciences' notable products is PerfusionPal, a high-throughput organ-on-a-chip insert system designed to enhance drug metabolism by up to 10 times. Notably, it doesn't require specialized training and ensures reliable performance, making it suitable for addressing complex questions in research. Another product, SeedEZ, is a universal and user-friendly 3D cell culture scaffold that facilitates the simulation of living tissues, compound testing, and functionality assessment. With GradientEZ, users can easily create controlled gradients, particularly beneficial for enhancing cancer and autoimmune models for testing therapeutic strategies. Lena Biosciences recently secured a $252.12K grant investment in August 2020, with the National Institute of Environmental Health Sciences being the investor. With its innovative technologies and focus on simplifying and enhancing in vitro research, Lena Biosciences is poised for significant impact in the biotechnology and pharmaceutical industries.